Optegra appoints Ghada Beal as UK managing director

Optegra Eye Health Care has appointed Ghada Beal as UK managing director as it continues its next phase of growth.

Beal brings more than 30 years’ healthcare experience to the role and joins Optegra after holding senior leadership and advisory positions across the pharmacy and healthcare sectors.

A qualified pharmacist, she spent 26 years with Boots in senior leadership roles and has subsequently advised businesses including Superdrug, Lloyds Pharmacy and fertility provider FutureLife.

Beal (pictured) will lead Optegra’s UK business, which comprises 19 hospitals, as the company enters its next phase of development under EssilorLuxottica’s ownership.

Commenting on her appointment, she said: ‘Joining Optegra brings together everything I value: talented colleagues, outstanding clinical care and a highly respected brand with an ambitious vision for the future.’

Ola Spencer, group chief operating officer at Optegra, said Beal’s ‘experience of leading large healthcare organisations through growth and transformation, combined with her clinical background, makes her exceptionally well placed to lead our UK business as we continue to invest in our hospitals, our people and our services as part of the EssilorLuxottica family.’

Franco-Italian eyewear group EssilorLuxottica acquired the pan-European ophthalmology group from private equity group MidEuropa in 2025.

‘Becoming part of EssilorLuxottica marks an exciting new chapter for Optegra,’ added Beal. ‘The group’s long-term commitment to innovation, technology and clinical excellence creates significant opportunities to expand access to advanced eye care and continue improving outcomes for patients throughout every stage of their eye health journey.’